Suppressive effect of docosahexaenoyl-lysophosphatidylcholine and 17-hydroxydocosahexaenoyl-lysophosphatidylcholine on levels of cytokines in spleen of mice treated with lipopolysaccharide

European Journal of Lipid Science and Technology

Volumn 114, Issue 2, 2012, Pages 114-122

  Jim, Mei Chen ^a   Hung, Nguyen Dang ^a   Yoo, Jae Myung ^a   Kim, Mee Ree ^a   Sok, Dai Eun ^a  

^a Chungnam National University   (South Korea)

Author keywords

Anti inflammatory; Docosahexaenoyl lysophosphatidylcholine; Interleukin; Lipopolysaccharide; Spleen

Indexed keywords

MUS;

EID: 84863170215     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201100169     Document Type: Article

References (36)

1. Serhan, C. N., Savill, J., Resolution of inflammation: The beginning programs the end. Nat. Immunol. 2005, 6, 1191-1197.
2. Serhan, C. N., Chiang, N., Van Dyke, T. E., Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8, 349-361.
3. Bannenberg, G., Serhan, C. N., Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta 2010, 1801, 1260-1273.
4. Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K. et al., Lipid mediator class switching during acute inflammation: Signals in resolution. Nat. Immunol. 2001, 2, 612-619.
5. Calder, P. C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S-1519S.
6. Hung, N. D., Kim, M. R., Sok, D. E., Anti-inflammatory action of arachidonoyl lysophosphatidylcholine or 15-hydroperoxy derivative in zymosan A-induced peritonitis. Prostaglandins Other Lipid Mediat. 2009, 90, 105-111.
7. Huang, L. S., Hung, N. D., Sok, D. E., Kim, M. R., Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory. Lipids 2010, 45, 225-236.
8. Fuchs, B., Schiller, U., Wagner, H., Häntzschel, H. et al., The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: Investigations by 31P NMR and MALDI-TOF MS. Clin. Biochem. 2005, 38, 925-933.
9. 2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 2006, 40, 376-387.
10. 2 in leukocyte activation and inflammatory responses. Atherosclerosis 2007, 191, 54-62.
11. Fuentes, L., Hernández, M., Fernández-Avilés, F. J., Crespo, M. S. et al., Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: Implications for the inflammatory. Circ. Res. 2002, 91, 681-688.
12. Hung, N. D., Kim, M. R., Sok, D. E., Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis. Inflammation 2011, 34, 147-160.
13. Croset, M., Brossard, N., Polette, A., Lagarde, M., Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem. J. 2000, 345, 61-67.
14. Polette, A., Deshayes, C., Chantegrel, B., Croset, M. et al., Synthesis of acetyl, docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance. Lipids 1999, 34, 1333-1337.
15. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3, 133-146.
16. Liu, Y., Shi, J., Lu, J., Meng, G. et al., Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge. Innate Immun. 2009, 15, 169-178.
17. Semaeva, E., Tenstad, O., Skavland, J., Enger, M. et al., Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammation. J. Immunol. 2010, 184, 4547-4556.
18. Preethi, K. C., Kuttan, G., Kuttan, R., Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian J. Exp Biol. 2009, 47, 113-120.
19. Lunin, S. M., Khrenov, M. O., Novoselova, T. V., Parfenyuk, S. B. et al., Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines and heat shock protein Hsp70 in inflammation-bearing mice. Immunol. Invest. 2008, 37, 858-870.
20. Arribas, B., Rodríguez-Cabezas, M. E., Comalada, M., Bailón, E. et al., Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br. J. Nutr. 2009, 101, 51-58.
21. Chen, S., Li, K. W., Mass spectrometric identification of molecular species of phosphatidylcholine and lysophosphatidylcholine extracted from shark liver. J. Agric. Food Chem. 2007, 55, 9670-9677.
22. Huang, L. S., Kim, M. R., Sok, D. E., Linoleoyl lysophosphatidylcholine is an efficient substrate for soybean lipoxygenase-1. Arch. Biochem. Biophys. 2006, 455, 119-126.
23. Huang, L. S., Kim, M. R., Sok, D. E., Oxygenation of 1-docosahexaenoyl lysophosphatidylcholine by lipoxygenases; conjugated hydroperoxydiene and dihydroxytriene derivatives. Lipids 2007, 42, 981-990.
24. Huang, L. S., Kim, M. R., Sok, D. E., Regulation of lipoxygenase activity by polyunsaturated lysophosphatidylcholines or their oxygenation derivatives. J. Agric. Food Chem. 2008, 56, 7808-7814.
25. Bidlack, W. R., Tappel, A. L., Damage to microsomal membrane by lipid peroxidation. Lipids 1973, 8, 177-182.
26. Roberts, J. C., Francetic, D. J., The importance of sample preparation and storage in glutathione analysis. Anal. Biochem. 1993, 211, 183-187.
27. Hassan, I. R., Gronert, K., Acute changes in dietary {omega}-3 and {omega}-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 2009, 182, 3223-3232.
28. Kolaczkowska, E., Arnold, B., Opdenakker, G., Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: Comparison of phase-specific production by mast cells, macrophages, and neutrophils. Immunobiology 2008, 213, 109-124.
29. Kolaczkowska, E., Shahzidi, S., Seljelid, R., Van Rooijen, N. et al., Early vascular permeability in murine experimental peritonitis is comediated by residential macrophages and mast cells: Crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 2002, 26, 61-71.
30. Hung, N. D., Kim, M. R., Sok, D. E., Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis. Br. J. Pharmacol. 2011, 162, 1119-1135.
31. Miller, C., Yamaguchi, R. Y., Ziboh, V. A., Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids. Lipids 1989, 24, 998-1003.
32. Huwile, A., Feilschifter, J. P., Lipids as targets for novel anti-inflammatory therapies. Pharmacol. Ther. 2009, 124, 96-112.
33. Colles, S. M., Chisolm, G. M., Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events. J. Lipid Res. 2000, 41, 1188-1198.
34. Takeshita, S., Inoue, N., Gao, D., Rikitake, Y. et al., Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. J. Atheroscler. Thromb. 2000, 7, 238-246.
35. Park, C. H., Kim, M. R., Han, J. M., Jeong, T. S. et al., Lysophosphatidylcholine exhibits a selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages. Lipids 2009, 44, 425-435.
36. Bernoud, N., Fenart, L., Molière, P., Dehouck, M. P. et al., Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J. Neurochem. 1999, 72, 338-345.